Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2026-01-31 @ 1:39 AM
Study NCT ID:
NCT06794268
Status:
RECRUITING
Last Update Posted:
2025-02-24
First Post:
2025-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
Sponsor:
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA082-1175
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None